In Vitro Permeation Test Studies for Topical Drug Products Submitted in ANDAs
In Vitro Permeation Test Studies for Topical Drug Products Submitted in ANDAs guidance is intended to assist applicants who are submitting abbreviated new drug…
Read more →M9 Biopharmaceutics Classification System Based Biowaivers
M9 Biopharmaceutics Classification System Based Biowaivers guidance is being provided by FDA. Two drug products containing the same drug substance or substances are considered…
Read more →Premenopausal Women with Breast Cancer: Developing Drugs for Treatment
Premenopausal Women with Breast Cancer: Developing Drugs for Treatment guidance provides recommendations to sponsors developing drugs or biological products regulated by CDER and CBER for…
Read more →Providing Regulatory Submissions in Electronic Format Standardized Study Data
Providing Regulatory Submissions in Electronic Format Standardized Study Data guidance and the technical specifications documents it incorporates by reference describe the requirements for an…
Read more →Evaluating Cancer Drugs in Patients with Central Nervous System Metastases
Evaluating Cancer Drugs in Patients with Central Nervous System Metastases guidance is to describe FDA’s recommendations for clinical trial designs of cancer drugs or…
Read more →FDA Export Certification
FDA Export Certification guidance document is intended to provide a general description of Food and Drug Administration (FDA or the Agency) export certification to…
Read more →